Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol Re-Restates: Income Taxes, “Grants” May Be Ongoing Issues

Executive Summary

Bristol-Myers Squibb still has work to do to resolve its income tax reporting processes, the company acknowledged in a 10-K filed with the Securities & Exchange Commission March 15

You may also be interested in...



Cardinal Revenue Classification Is Subject Of SEC/U.S. Attorney Investigation

Cardinal's revenue classification practices are the subject of an investigation by the Securities & Exchange Commission and the New York U.S. Attorney

Bristol Increases Wholesaler Inventory Liability Legal Reserves By $300 Mil.

Bristol-Myers Squibb plans to increase its legal reserves relating to wholesaler inventory issues by $300 mil., the second increase in three months

Cardinal Revenue Classification Is Subject Of SEC/U.S. Attorney Investigation

Cardinal's revenue classification practices are the subject of an investigation by the Securities & Exchange Commission and the New York U.S. Attorney

Related Content

UsernamePublicRestriction

Register

LL1134420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel